Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone pretreatment for prevention of opioid-induced cough during induction of general anesthesia
ChiCTR1900021087Phase 4Not yet recruiting
- Sponsor
- Department of Anesthesiology, Second Affiliated Hospital of Nanjing Medical University
- Start
- Jun 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oxycodone and sufentanil in cough (4 arms), sponsored by Department of Anesthesiology, Second Affiliated Hospital of Nanjing Medical University. Primary endpoint: Cough. Planned start Jun 2019; status: not yet recruiting.
02
Drugs
oxycodonesufentanil
03
Conditions
cough
Beyond the preview
Go deeper on ChiCTR1900021087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021087.